dementia, Mike Jeffries and Abercrombie & Fitch

Abercrombie & Fitch’s former CEO Mike Jeffries has dementia, his lawyers say
Mike Jeffries, the gay 80-year-old embattled former CEO of clothing brand Abercrombie & Fitch, has dementia and Alzheimer’s disease, his lawyers have said in court documents filed this week. They are requesting a hearing to determine if Jefferies is fit to stand trial for federal criminal charges in connection to sex trafficking.
Lawyer for ex-Abercrombie CEO says he has dementia
Bieber said he asked Jefferies to get a medical evaluation by a neuropsychologist, who later found that the ex-CEO “currently suffers from dementia with behavioral disturbance … Alzheimer’s disease with late onset (probable) … and Lewy body dementia,” according to court papers acquired by NBC.
Former Abercrombie & Fitch CEO Michael Jeffries Diagnosed with Dementia Amid Sex Trafficking Charges
Michael Jeffries has been diagnosed with dementia and late-onset Alzheimer’s disease, a diagnosis that comes as he faces charges of sex trafficking. RELATED STORIES: Whoah: Former Abercrombie and Fitch CEO Arrested in Sex Trafficking Investigation Jeffries was arrested last October along with his partner,
Victims' lawyer questions timing of dementia diagnosis of ex Abercrombie CEO Mike Jeffries
A lawyer for sex-trafficking victims in a ring allegedly run by ex-Abercrombie & Fitch CEO Mike Jeffries has doubts about claims he has dementia.
Lawyers for ex-Abercrombie CEO Michael Jeffries say dementia may leave him incompetent to face sex charges
Defense lawyers say the former longtime CEO of Abercrombie & Fitch may have dementia, and a competency hearing is necessary to determine if he can face sex charges. Lawyers for Michael Jeffries said in court papers unsealed Monday in federal court in Central Islip on Long Island that a neuropsychologist who examined Jeffries in October concluded he likely has dementia with behavioral disturbance,
Sumitomo Mitsui Eyes Deepening Jefferies Tieup in Global Push
Sumitomo Mitsui Financial Group Inc. is looking to expand its alliance with Jefferies Financial Group Inc., possibly working ...
We're going back to 2019 level neutral rates, says Jefferies' David Zervos
David Zervos, Jefferies chief market strategist, joins 'Squawk Box' to discuss the latest market trends, the Fed's inflation ...
Rocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'
Jefferies initiated a "buy" rating on Rocket Pharmaceuticals, based on the biotech firm's experimental gene therapies.
Costco, boosted by traffic and digital sales, is well positioned for future gains, says Jefferies
Costco Wholesale Corp., which reported first-quarter results after market close Thursday, is well placed for future share ...
Jefferies' Andy Barish gives his top restaurant picks for 2025
Andy Barish, Jefferies managing director of equity research, joins 'The Exchange' to discuss his restaurant outlook in 2025.
CoinDesk7d
Bitcoin Miners Are Expected to be Profitable in December, Jefferies Says
Bitcoin (BTC) miners are expected to be profitable in December as the world's largest cryptocurrency hit record highs earlier ...
Cantor Fitzgerald Bulks Up FIG Group with Jefferies, Cavu Hires
Cantor Fitzgerald & Co. has made some new hires to its financial institutions group, including Vishal Sitapara from Jefferies ...
Affirm upgraded to Buy at Jefferies on ‘collection of positive trends’
Jefferies upgraded Affirm (AFRM) to Buy from Hold with a price target of $82, up from $70. The firm’s upgrade is predicated ...
Jefferies upgrades WTW to Buy on ‘beat-and-raise story’
Jefferies analyst Yaron Kinar last night upgraded WTW (WTW) to Buy from Hold with a price target of $382, up from $352. The firm’s estimates ...
RenaissanceRe downgraded at Jefferies on expected moderating growth
Reinsurer RenaissanceRe Holdings (RNR) was downgraded to Hold from Buy, and the price target reduced to $282.00 from $304.00, ...